Svas Biosana Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	139.12	120.31	118.28	97.23	81.09
Other Revenue	2.43	1.97	3.35	2.29	0.91
Revenue	141.56	122.29	121.63	99.51	81.99
Revenue Growth (YoY)	15.76%	0.54%	22.23%	21.37%	6.11%
Cost of Revenue	101.47	87.92	89.37	70.78	58.53
Gross Profit	40.08	34.37	32.26	28.73	23.47
Selling, General & Admin	18.59	16.43	15.64	16.84	11.02
Amortization of Goodwill & Intangibles	2.55	1.9	1.79	1.81	1.76
Other Operating Expenses	3.17	2.63	2.37	-0	1.8
Operating Expenses	27.85	24.56	23.69	22.45	17.69
Operating Income	12.24	9.8	8.57	6.28	5.77
Interest Expense	-4.13	-4.36	-3.79	-1.86	-1.87
Interest & Investment Income	0.08	0.11	0.11	0.06	0
Currency Exchange Gain (Loss)	0.07	-0.04	0.03	-0.13	-0.12
Other Non Operating Income (Expenses)	0.42	0.64	0.6	0.34	0.23
EBT Excluding Unusual Items	8.69	6.16	5.51	4.68	4.02
Gain (Loss) on Sale of Investments	0.45	1.85	1.29	-	-
Asset Writedown	-	-	-	-0.03	-
Pretax Income	9.14	8.01	6.8	4.66	4.02
Income Tax Expense	2.37	2.13	1.67	1.09	0.86
Earnings From Continuing Operations	6.77	5.88	5.13	3.57	3.16
Net Income to Company	6.77	5.88	5.13	3.57	3.16
Minority Interest in Earnings	0	-0	-0	-0	-0
Net Income	6.77	5.87	5.12	3.57	3.16
Net Income to Common	6.77	5.87	5.12	3.57	3.16
Net Income Growth	15.24%	14.68%	43.52%	12.97%	25.70%
Shares Outstanding (Basic)	5	5	-	5	-
Shares Outstanding (Diluted)	5	5	-	5	-
Shares Change (YoY)	-1.74%	-	-	-	-
EPS (Basic)	1.29	1.10	-	0.66	-
EPS (Diluted)	1.29	1.10	-	0.66	-
EPS Growth	17.28%	-	-	-	-
Free Cash Flow	2.73	1.42	0.52	1.9	-0.08
Free Cash Flow Per Share	0.52	0.27	-	0.35	-
Dividend Per Share	-	0.250	0.300	-	-
Dividend Growth	-	-16.67%	-	-	-
Gross Margin	28.32%	28.10%	26.52%	28.87%	28.62%
Operating Margin	8.64%	8.02%	7.04%	6.31%	7.04%
Profit Margin	4.78%	4.80%	4.21%	3.59%	3.85%
Free Cash Flow Margin	1.93%	1.17%	0.43%	1.91%	-0.10%
EBITDA	17.58	15.05	13.59	11.07	10.3
EBITDA Margin	12.42%	12.31%	11.17%	11.13%	12.57%
D&A For EBITDA	5.34	5.25	5.02	4.79	4.53
EBIT	12.24	9.8	8.57	6.28	5.77
EBIT Margin	8.64%	8.02%	7.04%	6.31%	7.04%
Effective Tax Rate	25.93%	26.63%	24.60%	23.31%	21.33%
Revenue as Reported	142.67	122.77	122.34	102.28	81.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.